导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -12.15% | 3904/4773 |
| 近一周 | -1.56% | 2305/5465 |
| 近一月 | -8.05% | 4754/5421 |
| 近一季 | -18.18% | 4703/5231 |
| 近半年 | -21.15% | 4428/4920 |
| 近一年 | -6.54% | 3214/4394 |
| 近两年 | 36.16% | 2068/2954 |
| 近三年 | 5.74% | 1827/2253 |
| 成立以来 | 43.62% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
4.73% 476/4961 |
0.96% 3090/5312 |
- - |
- - |
| 2025 | 29.11% 1424/4813 |
-4.53% 3190/3635 |
0.09% 2764/4076 |
37.60% 904/4524 |
-1.80% 3018/4813 |
| 2024 | 2.73% 1961/3463 |
-2.19% 1328/2808 |
-7.67% 2108/3014 |
19.52% 837/3129 |
-4.83% 2496/3463 |
| 2023 | -29.65% 2056/2656 |
-3.03% 2061/2280 |
-5.80% 1536/2385 |
-15.07% 2210/2515 |
-9.33% 2335/2655 |
| 2022 | -24.75% 1251/2207 |
-15.71% 1061/1919 |
15.01% 183/2016 |
-16.79% 1502/2113 |
-6.71% 2019/2208 |
| 2021 | 46.17% 12/1822 |
-4.87% 892/1255 |
29.84% 47/1330 |
17.94% 64/1466 |
0.33% 1133/1822 |
| 2020 | 57.52% 139/1250 |
-6.31% 479/1028 |
15.52% 490/1067 |
16.06% 172/1164 |
25.40% 27/1184 |
| 2019 | 21.21% 653/1092 |
26.20% 422/754 |
-10.10% 713/804 |
-1.17% 636/850 |
8.10% 351/918 |
| 2018 | -34.86% 573/834 |
- - |
- - |
- - |
-8.51% 94/691 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 广发中证环保ETF VS. 长安沪深300非周期A(740101) |